Skip to main content
Caplight Logo









Evidentli

Evidentli

Private
SydneyHealthcare & Life Scienceshttps://evidentli.com

Last Round

Seed

Oct 1, 2022

Total Funding Raised

$14,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Evidentli operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Seed round in October 2022.

Evidentli is a health technology company that provides an AI-powered software platform to standardize, aggregate, and analyze complex real-world healthcare data for providers and researchers.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Clinical Trials, Medical AI, Data Integration, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Evidentli Comparables

Compare Evidentli with similar companies based on industry and business-model similarity.

Evidentli comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Promptly Health
83%
edenceHealth NV
78%
Cognome
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Evidentli Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 1, 2022
AcceleratorOct 30, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Evidentli Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Grew 20% QoQ, from 20 to 24 employees.

  • Nov 17, 2025

    Dr Kaveh Safavi joins as Non-Executive Director.

Book a demo to see all signals

For institutional investors. Book with your work email.

Evidentli Filings

Explore SEC and related filing metadata, where available.

Evidentli filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Evidentli's valuation, stock price, and market status.

Is Evidentli a public or private company?

Evidentli is a private company.

What is the current stock price of Evidentli?

Evidentli is a private company, so its shares have no public market price. Caplight tracks Evidentli's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Evidentli worth (valuation)?

Valuation information for Evidentli is not publicly available.

Can I buy Evidentli stock?

Evidentli shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Evidentli's last funding round?

Evidentli's most recent funding round was Seed on October 1, 2022.

Who are the main investors in Evidentli?

Key investors in Evidentli include Black Nova Venture Capital, Australian Medical Angels, Club Investible Syndicate, UNSW Founders, Investible.

Will Evidentli IPO soon?

No public IPO plans have been announced for Evidentli.

How can I track Evidentli secondary market activity?

Caplight tracks bids, offers, and trades in Evidentli's shares on secondary markets.

Firmographic Details

HeadquartersSydney
Employee Range19
Year Founded2018
Last FundingOct 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?